资讯

The topic selection oversight panel is mainly responsible for making the following decisions about topics that have been considered by the NICE team: selecting devices, diagnostics and digital health ...
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155] Medicine Not selected 10 April 2025 Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 ...